Spero Therapeutics
SPRO
#10353
Rank
โ‚ฌ39.41 M
Marketcap
0,68ย โ‚ฌ
Share price
-10.20%
Change (1 day)
-67.22%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2026 (TTM): โ‚ฌ5.27 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are โ‚ฌ42.96 Million. In 2025 the company made an earning of โ‚ฌ6.52 Million, an increase over its 2024 earnings that were of -โ‚ฌ66.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ5.27 M-19.11%
2025 โ‚ฌ6.52 M-109.88%
2024 -โ‚ฌ66.08 Million-360.42%
2023 โ‚ฌ25.37 M-163.53%
2022 -โ‚ฌ39.94 Million-50.14%
2021 -โ‚ฌ80.1 Million11.06%
2020 -โ‚ฌ72.12 Million25.15%
2019 -โ‚ฌ57.63 Million47.68%
2018 -โ‚ฌ39.03 Million5.61%
2017 -โ‚ฌ36.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
IBM
IBM
โ‚ฌ9.57 B 158,792.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
โ‚ฌ1.80 B 29,800.18%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
โ‚ฌ5.85 M-2.80%๐Ÿ‡บ๐Ÿ‡ธ USA